Related Experiment Video
Updated: Feb 6, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
High-Risk Neuroblastoma Treatment Review
Valeria Smith1, Jennifer Foster2
1Baylor College of Medicine Department of Pediatrics, Texas Children's Cancer and Hematology Center, Houston, TX 77030, USA. vs134101@bcm.edu.
Abstract:
Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survival rates. The current treatment schema is divided into three stages-induction, consolidation, and maintenance. This review serves as an overview of the current treatment for high-risk neuroblastoma and a glimpse at current research for future therapy.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

